| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2023―Mrz―13 |
RESPONSE OF LYMPHOPENIC PLATELETPHERESIS DONORS TO COVID-19 VACCINATION |
Renee Bazin, Annemarie Laumaea, Antoine Lewin, Debashree Chatterjee, Carl Simard, Tony Tremblay, et al. (+4) Pascal Rouleau, Marie-Eve Allard, Josee Perreault, Andres Finzi |
| 2 |
[GO] |
2023―Mrz―13 |
SARS-CoV-2 Seroprevalence in the Vaccine Era: The Canadian Blood Services Serosurvey January to November 2021 |
Sheila O'Brien, Cassandra Reedman, Qi-Long Yi, Steven Drews |
| 3 |
[GO] |
2022―Jun―10 |
Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins against SARS-CoV-2 |
Thierry Burnouf, Birgit Gathof, Evan M. Bloch, Renée Bazin, Vincenzo de Angelis, Gopal Kumar Patidar, et al. (+7) Rada M. Grubovic Rastvorceva, Adaeze Oreh, Ruchika Goel, Naomi Rahimi-Levene, Salwa Hindawi, Arwa Z. Al-Riyami, Cynthia So-Osman |
| 4 |
[GO] |
2022―Feb―28 |
Tracking SARS-CoV-2 seroprevalence among Canadian blood donors |
Sahar Saeed, Steven Drews, Chantale Pambrun, Qi-Long Yi, Lori Osmond, Sheila O'Brien |
| 5 |
[GO] |
2021―Okt―12 |
Convalescent plasma for patients hospitalised with Coronavirus disease 2019: A meta-analysis with trial sequential analysis of randomised controlled trials |
Ryan Ruiyang Ling, Jackie Jia Lin Sim, Felicia Liying Tan, Bee Choo Tai, Nicholas Syn, Sharavan Sadasiv Mucheli, et al. (+3) Bingwen Eugene Fan, Saikat Mitra, Kollengode Ramanathan |
| 6 |
[GO] |
2021―Jul―30 |
Characteristics of US Blood donors testing reactive for antibodies to SARS-CoV-2 prior to the availability of authorized vaccines |
Roger Y Dodd, Bryan R Spencer, Xu Meng, Gregory A Foster, Paula Saa, Jaye P Brodsky, Susan L Stramer |
| 7 |
[GO] |
2021―Jul―30 |
Progression and Predictors of SARS-CoV-2 Antibody Seroreactivity in US Blood Donors |
Ralph R. Vassallo, Larry J. Dumont, Marjorie D. Bravo, Kelsey Hazegh, Hany Kamel |
| 8 |
[GO] |
2020―Dez―04 |
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomized controlled trial (PLACID Trial). Agarwal A, Mukherjee A, Kumar G, et al. BMJ. 2020;371 |
Simon Stanworth |
| 9 |
[GO] |
2020―Jul―15 |
A Scoping Review of Registered Clinical Trials of Convalescent Plasma for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence - FAST Evidence |
Katina Zheng, Gary Liao, Manoj M. Lalu, Alan Tinmouth, Dean A. Fergusson, David S. Allan |
| 10 |
[GO] |
2020―Jun―27 |
A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence - FAST Evidence |
Gary Liao, Katina Zheng, Manoj M. Lalu, Dean A. Fergusson, David S. Allan |
| 11 |
[GO] |
2020―Jun―27 |
International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection |
MF Murphy, L Estcourt, J Grant-Casey, S Dzik |
| 12 |
[GO] |
2020―Apr―23 |
COVID-19 Convalescent Plasma: Now Is the Time for Better Science |
Sunny Dzik |
| 13 |
[GO] |
2020―Apr―23 |
Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic |
H. Cliff Sullivan, John D. Roback |
| 14 |
[GO] |
2020―Feb―26 |
COVID-19 and blood safety: help with a dilemma |
Roger Y. Dodd, Susan L. Stramer |
| 15 |
[GO] |
2020―Feb―21 |
Coronavirus Disease 2019: Coronaviruses and Blood Safety |
Le Chang, Ying Yan, Lunan Wang |
